{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:21:44Z","timestamp":1792167704663,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["24YF2734000"],"award-info":[{"award-number":["24YF2734000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-01108-x","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T07:41:13Z","timestamp":1756798873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gene augmentation therapy restores vision and preserves photoreceptors in a mouse model of CNGA1-retinitis pigmentosa"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0232-5100","authenticated-orcid":false,"given":"Yidong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyue","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2544-1254","authenticated-orcid":false,"given":"Tong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9341-5587","authenticated-orcid":false,"given":"Huixun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4583-8686","authenticated-orcid":false,"given":"Xiaoling","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5015-0945","authenticated-orcid":false,"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"1108_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1152\/physrev.00008.2002","volume":"82","author":"UB Kaupp","year":"2002","unstructured":"Kaupp, U. B. & Seifert, R. Cyclic nucleotide-gated ion channels. Physiol. Rev. 82, 769\u2013824 (2002).","journal-title":"Physiol. Rev."},{"key":"1108_CR2","doi-asserted-by":"publisher","first-page":"100772","DOI":"10.1016\/j.preteyeres.2019.07.005","volume":"74","author":"M Power","year":"2020","unstructured":"Power, M. et al. Cellular mechanisms of hereditary photoreceptor degeneration - Focus on cGMP. Prog. Retin. Eye Res. 74, 100772 (2020).","journal-title":"Prog. Retin. Eye Res."},{"key":"1108_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev.physiol.64.082701.102229","volume":"64","author":"VY Arshavsky","year":"2002","unstructured":"Arshavsky, V. Y., Lamb, T. D. & Pugh, E. N. Jr G proteins and phototransduction. Annu. Rev. Physiol. 64, 153\u2013187 (2002).","journal-title":"Annu. Rev. Physiol."},{"key":"1108_CR4","doi-asserted-by":"publisher","first-page":"10177","DOI":"10.1073\/pnas.92.22.10177","volume":"92","author":"TP Dryja","year":"1995","unstructured":"Dryja, T. P. et al. Mutations in the gene encoding the alpha subunit of the rod cGMP-gated channel in autosomal recessive retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 92, 10177\u201310181 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1108_CR5","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong, D. T., Berson, E. L. & Dryja, T. P. Retinitis pigmentosa. Lancet 368, 1795\u20131809 (2006).","journal-title":"Lancet"},{"key":"1108_CR6","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1167\/iovs.12-10967","volume":"54","author":"X Chen","year":"2013","unstructured":"Chen, X. et al. Targeted sequencing of 179 genes associated with hereditary retinal dystrophies and 10 candidate genes identifies novel and known mutations in patients with various retinal diseases. Invest. Ophthalmol. Vis. Sci. 54, 2186\u20132197 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1108_CR7","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1073\/pnas.1913179117","volume":"117","author":"M Hanany","year":"2020","unstructured":"Hanany, M., Rivolta, C. & Sharon, D. Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases. Proc. Natl. Acad. Sci. USA 117, 2710\u20132716 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1108_CR8","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.ophtha.2019.04.038","volume":"126","author":"FJ Gao","year":"2019","unstructured":"Gao, F. J. et al. Genetic anD CLINICAL FINDINGS IN A LARGE COHORT OF CHINESE PATIENTS WITH SUSPECTEd Retinitis Pigmentosa. Ophthalmology 126, 1549\u20131556 (2019).","journal-title":"Ophthalmology"},{"key":"1108_CR9","doi-asserted-by":"publisher","first-page":"E66","DOI":"10.1136\/jmg.39.10.e66","volume":"39","author":"E Paloma","year":"2002","unstructured":"Paloma, E. et al. Novel homozygous mutation in the alpha subunit of the rod cGMP gated channel (CNGA1) in two Spanish sibs affected with autosomal recessive retinitis pigmentosa. J. Med. Genet. 39, E66 (2002).","journal-title":"J. Med. Genet."},{"key":"1108_CR10","doi-asserted-by":"publisher","first-page":"e108721","DOI":"10.1371\/journal.pone.0108721","volume":"9","author":"S Katagiri","year":"2014","unstructured":"Katagiri, S. et al. Whole exome analysis identifies frequent CNGA1 mutations in Japanese population with autosomal recessive retinitis pigmentosa. PLoS One 9, e108721 (2014).","journal-title":"PLoS One"},{"key":"1108_CR11","first-page":"884","volume":"10","author":"Q Zhang","year":"2004","unstructured":"Zhang, Q. et al. Autosomal recessive retinitis pigmentosa in a Pakistani family mapped to CNGA1 with identification of a novel mutation. Mol. Vis. 10, 884\u2013889 (2004).","journal-title":"Mol. Vis."},{"key":"1108_CR12","doi-asserted-by":"publisher","first-page":"877752","DOI":"10.3389\/fmed.2022.877752","volume":"9","author":"Z Ye","year":"2022","unstructured":"Ye, Z. et al. Case Report: The First Reported Concurrence of Wilson Disease and Bilateral Retinitis Pigmentosa. Front. Med. 9, 877752 (2022).","journal-title":"Front. Med."},{"key":"1108_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s10528-019-09907-3","volume":"57","author":"Q Gao","year":"2019","unstructured":"Gao, Q. et al. A novel CNGA1 GENE MUtation (c.G622A) of autosomal recessive Retinitis Pigmentosa leads to the CNGA1 protein reduction on membrane. Biochem. Genet. 57, 540\u2013554 (2019).","journal-title":"Biochem. Genet."},{"key":"1108_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-016-0281-6","volume":"16","author":"M Wang","year":"2016","unstructured":"Wang, M., Gan, D., Huang, X. & Xu, G. Novel compound heterozygous mutations in CNGA1in a Chinese family affected with autosomal recessive retinitis pigmentosa by targeted sequencing. BMC Ophthalmol. 16, 101 (2016).","journal-title":"BMC Ophthalmol."},{"key":"1108_CR15","doi-asserted-by":"publisher","first-page":"e00289","DOI":"10.1042\/BSR20150131","volume":"36","author":"X Jin","year":"2016","unstructured":"Jin, X. et al. Novel compound heterozygous mutation in the CNGA1 gene underlie autosomal recessive retinitis pigmentosa in a Chinese family. Biosci. Rep. 36, e00289 (2016).","journal-title":"Biosci. Rep."},{"key":"1108_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84098-9","volume":"11","author":"K Saito","year":"2021","unstructured":"Saito, K. et al. A case of retinitis pigmentosa homozygous for a rare CNGA1 causal variant. Sci. Rep. 11, 4681 (2021).","journal-title":"Sci. Rep."},{"key":"1108_CR17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell, S. et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390, 849\u2013860 (2017).","journal-title":"Lancet"},{"key":"1108_CR18","doi-asserted-by":"publisher","unstructured":"Gerhardt, M. J., Priglinger, S. G., Biel, M. & Michalakis, S. Biology, pathobiology and gene therapy of CNG channel-related retinopathies. Biomedicines 11 https:\/\/doi.org\/10.3390\/biomedicines11020269 (2023).","DOI":"10.3390\/biomedicines11020269"},{"key":"1108_CR19","doi-asserted-by":"publisher","first-page":"108232","DOI":"10.1016\/j.visres.2023.108232","volume":"208","author":"MJ Gerhardt","year":"2023","unstructured":"Gerhardt, M. J., Petersen-Jones, S. M. & Michalakis, S. CNG channel-related retinitis pigmentosa. Vis. Res. 208, 108232 (2023).","journal-title":"Vis. Res."},{"key":"1108_CR20","doi-asserted-by":"publisher","first-page":"e21859","DOI":"10.1096\/fj.202101004R","volume":"35","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Retinal degeneration in mice lacking the cyclic nucleotide-gated channel subunit CNGA1. FASEB J. 35, e21859 (2021).","journal-title":"FASEB J."},{"key":"1108_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40655-6","volume":"14","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa. Nat. Commun. 14, 4923 (2023).","journal-title":"Nat. Commun."},{"key":"1108_CR22","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1093\/hmg\/dds290","volume":"21","author":"S Koch","year":"2012","unstructured":"Koch, S. et al. Gene therapy restores vision and delays degeneration in the CNGB1(-\/-) mouse model of retinitis pigmentosa. Hum. Mol. Genet. 21, 4486\u20134496 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"1108_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.eye.6703076","volume":"23","author":"S Aizawa","year":"2009","unstructured":"Aizawa, S. et al. Correlation between visual function and photoreceptor inner\/outer segment junction in patients with retinitis pigmentosa. Eye 23, 304\u2013308 (2009).","journal-title":"Eye"},{"key":"1108_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/ceo.12685","volume":"44","author":"LW Tao","year":"2016","unstructured":"Tao, L. W., Wu, Z., Guymer, R. H. & Luu, C. D. Ellipsoid zone on optical coherence tomography: a review. Clin. Exp. Ophthalmol. 44, 422\u2013430 (2016).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"1108_CR25","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1111\/aos.14542","volume":"99","author":"Y Gong","year":"2021","unstructured":"Gong, Y., Chen, L. J., Pang, C. P. & Chen, H. Ellipsoid zone optical intensity reduction as an early biomarker for retinitis pigmentosa. Acta Ophthalmol. 99, e215\u2013e221 (2021).","journal-title":"Acta Ophthalmol."},{"key":"1108_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/13816810.2020.1780619","volume":"41","author":"JK Oh","year":"2020","unstructured":"Oh, J. K., Nuzbrokh, Y., Lima de Carvalho, J. R. Jr., Ryu, J. & Tsang, S. H. Optical coherence tomography in the evaluation of retinitis pigmentosa. Ophthalm. Genet. 41, 413\u2013419 (2020).","journal-title":"Ophthalm. Genet."},{"key":"1108_CR27","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.2741\/3409","volume":"14","author":"N Tanimoto","year":"2009","unstructured":"Tanimoto, N. et al. Vision tests in the mouse: Functional phenotyping with electroretinography. Front Biosci. (Landmark Ed.) 14, 2730\u20132737 (2009).","journal-title":"Front Biosci. (Landmark Ed.)"},{"key":"1108_CR28","doi-asserted-by":"publisher","unstructured":"Benchorin, G., Calton, M. A., Beaulieu, M. O. & Vollrath, D. Assessment of murine retinal function by Electroretinography. Bio Protoc. 7, https:\/\/doi.org\/10.21769\/BioProtoc.2218 (2017).","DOI":"10.21769\/BioProtoc.2218"},{"key":"1108_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","volume":"144","author":"AG Robson","year":"2022","unstructured":"Robson, A. G. et al. ISCEV Standard for full-field clinical electroretinography (2022 update). Doc. Ophthalmol. 144, 165\u2013177 (2022).","journal-title":"Doc. Ophthalmol."},{"key":"1108_CR30","first-page":"506","volume":"42","author":"GB Jaissle","year":"2001","unstructured":"Jaissle, G. B. et al. Evaluation of the rhodopsin knockout mouse as a model of pure cone function. Invest. Ophthalmol. Vis. Sci. 42, 506\u2013513 (2001).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1108_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35996-7","volume":"13","author":"JC Park","year":"2023","unstructured":"Park, J. C. et al. Effects of normal aging on the mouse retina assessed by full-field flash and flicker electroretinography. Sci. Rep. 13, 8860 (2023).","journal-title":"Sci. Rep."},{"key":"1108_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF00153014","volume":"63","author":"K Yagasaki","year":"1986","unstructured":"Yagasaki, K., Miyake, Y., Litao, R. E. & Ichikawa, K. Two cases of retinal degeneration with an unusual form of electroretinogram. Doc. Ophthalmol. 63, 73\u201382 (1986).","journal-title":"Doc. Ophthalmol."},{"key":"1108_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/bjo.68.2.69","volume":"68","author":"KR Alexander","year":"1984","unstructured":"Alexander, K. R. & Fishman, G. A. Supernormal scotopic ERG in cone dystrophy. Br. J. Ophthalmol. 68, 69\u201378 (1984).","journal-title":"Br. J. Ophthalmol."},{"key":"1108_CR34","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.1167\/iovs.10-5421","volume":"51","author":"MJ Phillips","year":"2010","unstructured":"Phillips, M. J. et al. Retinal function and structure in Ant1-deficient mice. Invest. Ophthalmol. Vis. Sci. 51, 6744\u20136752 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1108_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1523\/JNEUROSCI.3764-04.2005","volume":"25","author":"S H\u00fcttl","year":"2005","unstructured":"H\u00fcttl, S. et al. Impaired channel targeting and retinal degeneration in mice lacking the cyclic nucleotide-gated channel subunit CNGB1. J. Neurosci. 25, 130\u2013138 (2005).","journal-title":"J. Neurosci."},{"key":"1108_CR36","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","volume":"30","author":"A Pupo","year":"2022","unstructured":"Pupo, A. et al. AAV vectors: The Rubik\u2019s cube of human gene therapy. Mol. Ther. 30, 3515\u20133541 (2022).","journal-title":"Mol. Ther."},{"key":"1108_CR37","doi-asserted-by":"publisher","unstructured":"Li, S., Ma, H., Yang, F. & Ding, X. cGMP Signaling in Photoreceptor Degeneration. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms241311200 (2023).","DOI":"10.3390\/ijms241311200"},{"key":"1108_CR38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1172\/JCI95161","volume":"128","author":"SM Petersen-Jones","year":"2018","unstructured":"Petersen-Jones, S. M. et al. Patients and animal models of CNG\u03b21-deficient retinitis pigmentosa support gene augmentation approach. J. Clin. Invest. 128, 190\u2013206 (2018).","journal-title":"J. Clin. Invest."},{"key":"1108_CR39","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1089\/hum.2021.121","volume":"32","author":"JE Wagner","year":"2021","unstructured":"Wagner, J. E. et al. In vivo potency testing of subretinal rAAV5.hCNGB1 gene therapy in the Cngb1 Knockout Mouse Model of Retinitis Pigmentosa. Hum. Gene Ther. 32, 1158\u20131170 (2021).","journal-title":"Hum. Gene Ther."},{"key":"1108_CR40","doi-asserted-by":"publisher","unstructured":"Occelli, L. M. et al. Development of a translatable gene augmentation therapy for CNGB1-retinitis pigmentosa. Mol. Ther. https:\/\/doi.org\/10.1016\/j.ymthe.2023.04.005 (2023).","DOI":"10.1016\/j.ymthe.2023.04.005"},{"key":"1108_CR41","first-page":"917","volume":"41","author":"L Leconte","year":"2000","unstructured":"Leconte, L. & Barnstable, C. J. Impairment of rod cGMP-gated channel alpha-subunit expression leads to photoreceptor and bipolar cell degeneration. Invest. Ophthalmol. Vis. Sci. 41, 917\u2013926 (2000).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1108_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/age.12323","volume":"46","author":"AC Wiik","year":"2015","unstructured":"Wiik, A. C. et al. Progressive retinal atrophy in Shetland sheepdog is associated with a mutation in the CNGA1 gene. Anim. Genet. 46, 515\u2013521 (2015).","journal-title":"Anim. Genet."},{"key":"1108_CR43","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41420-022-01185-0","volume":"8","author":"S Kandaswamy","year":"2022","unstructured":"Kandaswamy, S. et al. Mutations within the cGMP-binding domain of CNGA1 causing autosomal recessive retinitis pigmentosa in human and animal model. Cell Death Discov. 8, 387 (2022).","journal-title":"Cell Death Discov."},{"key":"1108_CR44","doi-asserted-by":"publisher","first-page":"103334","DOI":"10.1016\/j.scr.2024.103334","volume":"76","author":"Y Wu","year":"2024","unstructured":"Wu, Y. et al. Establishment of the induced pluripotent stem cell line SJTUGHi002-A from a CNGA1-related recessive retinitis pigmentosa patient. Stem Cell Res. 76, 103334 (2024).","journal-title":"Stem Cell Res."},{"key":"1108_CR45","doi-asserted-by":"publisher","unstructured":"Ayala, A., Cheetham, J., Durham, T. & Maguire, M. The Importance of Natural History Studies in Inherited Retinal Diseases. Cold Spring Harb. Perspect. Med. 13, https:\/\/doi.org\/10.1101\/cshperspect.a041297 (2023).","DOI":"10.1101\/cshperspect.a041297"},{"key":"1108_CR46","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1172\/JCI82462","volume":"125","author":"SF Koch","year":"2015","unstructured":"Koch, S. F. et al. Halting progressive neurodegeneration in advanced retinitis pigmentosa. J. Clin. Invest. 125, 3704\u20133713 (2015).","journal-title":"J. Clin. Invest."},{"key":"1108_CR47","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1073\/pnas.1615394114","volume":"114","author":"SF Koch","year":"2017","unstructured":"Koch, S. F. et al. Genetic rescue models refute nonautonomous rod cell death in retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 114, 5259\u20135264 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1108_CR48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00018-022-04161-0","volume":"79","author":"J Kajtna","year":"2022","unstructured":"Kajtna, J., Tsang, S. H. & Koch, S. F. Late-stage rescue of visually guided behavior in the context of a significantly remodeled retinitis pigmentosa mouse model. Cell. Mol. Life Sci. 79, 148 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"1108_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44063-8","volume":"14","author":"ML Scalabrino","year":"2023","unstructured":"Scalabrino, M. L. et al. Late gene therapy limits the restoration of retinal function in a mouse model of retinitis pigmentosa. Nat. Commun. 14, 8256 (2023).","journal-title":"Nat. Commun."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01108-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01108-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01108-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:39Z","timestamp":1756902159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01108-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1108"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01108-x","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.W. is an equity owner of Innostellar Biotherapeutics, a company developing human gene therapies. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"384"}}